Hershey Trust Company’s Health Catalyst HCAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-4,218
Closed -$123K 25
2020
Q2
$123K Sell
4,218
-6,327
-60% -$175K ﹤0.01% 14
2020
Q1
$276K Buy
+10,545
New +$322K ﹤0.01% 16

Other funds holding HCAT

Hershey Trust Company's HCAT Position: Q3 2020 in Review

Hershey Trust Company sold out of Health Catalyst (HCAT) in Q3 2020, closing a stake of 4,218 shares — an estimated $123K sold.

Hershey Trust Company first reported a position in HCAT in Q1 2020 and held it in 2 quarters. The position peaked at $276K in Q1 2020. 138 funds tracked by Wall St. Rank hold HCAT as of Q3 2020.

  • Hershey Trust Company reported no remaining Health Catalyst position as of Q3 2020 after selling out during the quarter.
  • Hershey Trust Company sold 4,218 Health Catalyst shares in Q3 2020, an estimated $123K.
  • Hershey Trust Company first reported a position in Health Catalyst in Q1 2020 and held it in 2 quarters.
  • Hershey Trust Company's Health Catalyst position peaked at $276K in Q1 2020.
  • 138 funds tracked by Wall St. Rank held Health Catalyst as of Q3 2020.

Based on Hershey Trust Company's 13F filing for Q3 2020, filed 23 Oct 2020.